publication/
10 pages · Updated May 17, 2026
Pages
- Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.
- Predictors of All-Cause Healthcare Payments Among Patients with Treatment-Resistant Major Depressive Disorder
- Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
- Treatment, HSCT Patterns, and Survival of Elderly Diffuse Large B-Cell Lymphoma Patients in the SEER-Medicare Linked Database
- Travel Burden Associated with Rare Cancers: The Example of Merkel Cell Carcinoma
- Referral Pathways in the Evaluation of Syncope
- Pregnancy rates and outcomes in women with and without MS in the United States
- Changes over time in treatment among patients with Rheumatoid Arthritis (RA) in Japan: Evidence from JMDC Inc. Database
- Real World Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Treating Patients with Atherosclerotic Cardiovascular Disease – an EMR Analysis of an Integrated Delivery Network
- Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders